Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5643)
All Articles published online
|
Publishing Process of This Article
|
Aug 15, 2013 (publication date) through Jan 29, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Pathophysiology
ISSN
2150-5330
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ierardi E, Giorgio F, Piscitelli D, Principi M, Cantatore S, Fiore MG, Rossi R, Barone M, Di Leo A, Panella C. Altered molecular pattern of mucosal healing in Crohn’s disease fibrotic stenosis. World J Gastrointest Pathophysiol 2013; 4(3): 53-58 [PMID: 23946888 DOI: 10.4291/wjgp.v4.i3.53] |
|---|---|
| URL: | https://www.wjgnet.com/2150-5330/full/v4/i3/53.htm |
| Number | Citing Articles |
| 1 |
Antonio Tursi. New physiopathological and therapeutic approaches to diverticular disease: an update. Expert Opinion on Pharmacotherapy 2014; 15(7): 1005 doi: 10.1517/14656566.2014.903922
|
| 2 |
A. Tursi, W. Elisei, G. M. Giorgetti, C. D. Inchingolo, R. Nenna, M. Picchio, F. Giorgio, E. Ierardi, G. Brandimarte. Expression of basic fibroblastic growth factor, syndecan 1 and tumour necrosis factor α in resected acute colonic diverticulitis. Colorectal Disease 2014; 16(3) doi: 10.1111/codi.12504
|
| 3 |
Antonio Tursi, Walter Elisei, Cosimo Damiano Inchingolo, Rosanna Nenna, Marcello Picchio, Enzo Ierardi, Giovanni Brandimarte. Chronic diverticulitis and Crohn's disease share the same expression of basic fibroblastic growth factor, syndecan 1 and tumour necrosis factor-α. Journal of Clinical Pathology 2014; 67(9): 844 doi: 10.1136/jclinpath-2013-202137
|
| 4 |
Debby Laukens. Fibrostenotic Inflammatory Bowel Disease. 2018; : 77 doi: 10.1007/978-3-319-90578-5_6
|
| 5 |
D. A. Davydov, V. N. Marchenko, O. B. Shchukina, V. I. Trofimov, D. A. Kuznetsova, I. V. Kholopova, S. V. Lapin, T. A. Lozovaya, A. A. Rubinstein, E. A. Nikiforova, T. D. Vlasov. Microvascular impairments in axial spondyloarthritis associated with Crohn’s disease. Regional blood circulation and microcirculation 2025; 23(4): 86 doi: 10.24884/1682-6655-2024-23-4-86-97
|
| 6 |
Cem Çekiç, Adnan Kırcı, Sezgin Vatansever, Fatih Aslan, Huriye Erbak Yılmaz, Emrah Alper, Mahmut Arabul, Elif Sarıtaş Yüksel, Belkıs Ünsal. Serum Syndecan-1 Levels and Its Relationship to Disease Activity in Patients with Crohn’s Disease. Gastroenterology Research and Practice 2015; 2015: 1 doi: 10.1155/2015/850351
|
| 7 |
Doron Yablecovitch, Assaf Stein, Maytal Shabat-Simon, Timna Naftali, Gila Gabay, Ido Laish, Asaf Oren, Fred M. Konikoff. Soluble Syndecan-1 Levels Are Elevated in Patients with Inflammatory Bowel Disease. Digestive Diseases and Sciences 2015; 60(8): 2419 doi: 10.1007/s10620-015-3589-9
|
| 8 |
Ioannis Drygiannakis, George Kolios, Eirini Filidou, Giorgos Bamias, Vassilis Valatas. Intestinal Stromal Cells in the Turmoil of Inflammation and Defective Connective Tissue Remodeling in Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2024; 30(9): 1604 doi: 10.1093/ibd/izae066
|